HindBio Science Stock Price Today (NSE: HINDIBIO)
Fundamental Score
HindBio Science Share Price — Live NSE/BSE Price, Fundamentals & Analysis
HindBio Science share price today is ₹7.40, up +0.00% on NSE/BSE as of 1 August 2026. HindBio Science (HINDIBIO) is a Small-cap company in the Software Products sector with a market capitalisation of ₹7.59 (Cr). The 52-week high for HINDIBIO share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -9.25% and a debt-to-equity ratio of 2.83.
HindBio Science Share Price Chart — NSE/BSE Historical Performance
HindBio Science share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.
AI Research Briefing
Powered by Gemini · 2026-08-01
A zero-revenue micro-cap shell bleeding capital with 2.83x D/E and 12.19% promoter skin in the game.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Hindustan Bio Sciences delivered another operational blank in Q1 FY27 (quarter ended June 2026), posting ₹0.00 crore in sales (-100% YoY) and a net loss of ₹0.11 crore compared to a net profit of ₹0.01 crore in June 2025. This follows a quarter ended March 2026 where sales were also zero with a net loss of ₹0.12 crore, dragging full-year FY26 sales down 8.64% to ₹0.74 crore. Management turbulence persists with Company Secretary Devanshu Dange resigning effective July 31, 2026, replaced by Shailendra Vyas on August 1, 2026.
CORE STORY (THE REAL GAME)
This is a micro-cap shell with severe fundamental distress, not a viable software or biotech growth play. The business repeatedly hits zero top-line quarters while bleeding cash on fixed expenses and interest overheads.
- Q1 FY27 reported ₹0.00 Cr sales with a net loss of ₹0.11 Cr
- Resignation of Key Managerial Personnel (Company Secretary) effective July 31, 2026
- FY26 total sales down to ₹0.74 Cr with full-year loss of ₹0.08 Cr
- Potential capital infusion or promoter stake purchase
- Insolvency/debt restructuring announcements
- Speculative micro-cap momentum spikes on low volume
- Zero revenue reported in consecutive quarters (March & June 2026)
- High leverage with Debt/Equity at 2.83x and negative ROE of -9.25%
- Micro/SME cap with severe illiquidity risk and 12.19% promoter holding
Zero institutional interest (0.0% FII, 0.0% DII); promoter holding stagnant at a low 12.19% with zero net change.
Broader tech and software product sectors require scale and R&D capital, leaving capital-starved micro-caps vulnerable to total obsolescence.
No major order wins found after live search; sales collapsed to ₹0.00 Cr in latest quarter.
No — negative cash generation with 5Y cumulative FCF of ₹-1.5 Cr.
High risk of further capital erosion and insolvency without immediate revenue revival or external capital injection.
Primary Thesis Risk
Persistent zero-revenue quarters leading to debt default or corporate restructuring.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
HindBio Science Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
HindBio Science Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HINDIBIO across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (-9.25%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-2.43%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-11.14%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-209.09%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-6.40% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Elevated Debt Levels (D/E: 2.83)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-1.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (12.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
HindBio Science vs Software Products Peers
Peer Comparison - Software Products
Compare HindBio Science with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
HindBio ScienceHindBio Science...Selected✓ HINDIBIO • 532041 | 0.3/100 | ₹7.40₹7 | ₹7.59₹7.59 | — — | -9.25%Poor -9.25% Poor | -2.43%Poor -2.43% Poor | 2.83Poor 2.8 Poor | 13.88%Good 13.88% Good | -6.40%Poor -6.40% Poor | 0.00% |
63.3/100 | ₹11186.00₹11186 | ₹101190.51₹101190.51 | 38.34Average 38.3 Average | 32.61%Excellent 32.61% Excellent | 45.28%Excellent 45.28% Excellent | 0.00Excellent 0.0 Excellent | 8.42%Good 8.42% Good | 9.01%Good 9.01% Good | 3.44% | |
Tanla Platforms LtdTanla Platforms... TANLA • 532790 | 65.5/100 | ₹586.55₹587 | ₹7484.41₹7484.41 | 14.70Average 14.7 Average | 21.41%Excellent 21.41% Excellent | 26.32%Excellent 26.32% Excellent | 0.02Excellent 0.0 Excellent | 7.50%Good 7.50% Good | 13.54%Good 13.54% Good | 2.13% |
Ce Info Systems LtdCe Info Systems... MAPMYINDIA • 543425 | 59.2/100 | ₹1181.65₹1182 | ₹6444.54₹6444.54 | 48.04Average 48.0 Average | 15.82%Good 15.82% Good | 22.00%Excellent 22.00% Excellent | 0.01Excellent 0.0 Excellent | 22.86%Excellent 22.86% Excellent | 25.47%Excellent 25.47% Excellent | 0.30% |
Ramco Systems LtdRamco Systems L... RAMCOSYS • 532370 | 48.2/100 | ₹580.90₹581 | ₹3060.85₹3060.85 | 50.97Average 51.0 Average | 18.04%Good 18.04% Good | 19.33%Good 19.33% Good | 0.12Excellent 0.1 Excellent | 1.47%Average 1.47% Average | 2.28%Average 2.28% Average | 0.00% |
Lucent Industries LtdLucent Industri... LUCENT • 539682 | 43.2/100 | ₹1180.55₹1181 | ₹2424.83₹2424.83 | 82.62Average 82.6 Average | 55.54%Excellent 55.54% Excellent | 75.89%Excellent 75.89% Excellent | 0.14Excellent 0.1 Excellent | — — | — — | 0.06% |
Nucleus Software Exports LtdNucleus Softwar... NUCLEUS • 531209 | 47.2/100 | ₹686.05₹686 | ₹2011.39₹2011.39 | 17.86Average 17.9 Average | 13.08%Average 13.08% Average | 16.83%Good 16.83% Good | 0.01Excellent 0.0 Excellent | 1.95%Average 1.95% Average | 11.27%Good 11.27% Good | 1.64% |
Blue Cloud Softech Solutions LtdBlue Cloud Soft... BLUECLOUDS • 539607 | 21.6/100 | ₹19.50₹20 | ₹1994.78₹1994.78 | 32.97Average 33.0 Average | 11.58%Average 11.58% Average | 14.16%Average 14.16% Average | 0.29Excellent 0.3 Excellent | — — | — — | 0.00% |
Unicommerce eSolutions LtdUnicommerce eSo... UNIECOM • 544227 | 21.9/100 | ₹87.58₹88 | ₹965.01₹965.01 | 47.17Average 47.2 Average | 15.55%Good 15.55% Good | 21.09%Excellent 21.09% Excellent | 0.05Excellent 0.1 Excellent | — — | — — | 0.00% |
Quick Heal Technologies LtdQuick Heal Tech... QUICKHEAL • 539678 | 14.2/100 | ₹152.88₹153 | ₹897.35₹897.35 | — — | -2.49%Poor -2.49% Poor | -4.65%Poor -4.65% Poor | 0.00Excellent 0.0 Excellent | — — | -4.76%Poor -4.76% Poor | 0.00% |
Subex LtdSubex Ltd... SUBEXLTD • 532348 | 29.7/100 | ₹12.33₹12 | ₹757.62₹757.62 | 23.62Average 23.6 Average | 9.91%Poor 9.91% Poor | 13.07%Average 13.07% Average | 0.08Excellent 0.1 Excellent | -8.46%Poor -8.46% Poor | -5.59%Poor -5.59% Poor | 0.00% |
Top Software Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Oracle Financial Services Software Limited share price101190.51 Cr
- Tanla Platforms Ltd share price7484.41 Cr
- Ce Info Systems Ltd share price6444.54 Cr
- Ramco Systems Ltd share price3060.85 Cr
- Lucent Industries Ltd share price2424.83 Cr
HindBio Science Quarterly Performance
Latest quarterly metrics for HINDIBIO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-100.00%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-209.09%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-6.40%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
13.88%
Compounded annual net profit growth over 5 years
HindBio Science Financial Statements
Annual income statement, balance sheet and cash flow for HindBio Science (HINDIBIO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for HindBio Science
About HINDIBIO (HindBio Science)
HindBio Science (HINDIBIO) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Software Products sector with a curr...ent market capitalisation of ₹7.59 (Cr). HindBio Science has delivered a Return on Equity (ROE) of -9.25% and a ROCE of -2.43%. The debt-to-equity ratio stands at 2.83, reflecting the company's capital structure. Investors tracking HINDIBIO share price can monitor key metrics including P/E ratio, promoter holding of 12.19%, and quarterly earnings growth.
Company Details
HINDIBIO Share Price: Frequently Asked Questions
What is the current share price of HindBio Science?
HindBio Science (HINDIBIO) trades at ₹7.40 on NSE and BSE. Market cap ₹7.59 (Cr). Educational data only.
What is the P/E ratio of HindBio Science?
HindBio Science has a P/E of N/Ax vs industry average 34.85x.
What is the Bull Run score for HindBio Science?
HindBio Science has a Bull Run score of 0.3/100 based on 25+ financial parameters.
Does HindBio Science pay dividends?
HindBio Science has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of HindBio Science?
HindBio Science has ROE of -9.25%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of HindBio Science?
HindBio Science has debt-to-equity of 2.83.
Is HindBio Science a good investment?
Bull Run gives HindBio Science a score of 0.3/100. This is not investment advice — consult a SEBI-registered advisor.